Non-pancreatic hyperlipasemia: A puzzling clinical entity

Table 2 Etiologic classification of hyperlipasemia without acute pancreatitis

	Patients number (n = 401)	Percentage (%)
Gastric and bowel disorders
Peptic ulcer	2	0.5
GI bleeding	4	1
Bowel necrosis/perforation	4	1
Bowel obstruction	8	2
IBD	5	1.2
Hepatobiliary disorders
Cholecystitis	8	2
Cholangitis	13	3.2
Liver disease	14	3.5
Post-ERCP lipasemia	16	4
Cancers
Pancreatic cancers	22	5.5
Non-pancreatic cancers	27	6.7
Haematological malignancies	6	1.5
Diabetes
Type 2 diabetes mellitus	19	4.7
Diabetic ketoacidosis	6	1.5
Neurosurgical pathology	16	4
Cardiovascular disease	17	4.2
Drugs side effect	17	4.2
Other	5	1.2
Infection without sepsis	30	7.5
Infection with sepsis
Sepsis without AKI	29	7.2
Sepsis with AKI	82	20.4
AKI without sepsis	51	12.7

All patients had elevated serum lipase level (> 210 U/L). GI: Gastrointestinal; IBD: Inflammatory bowel disease; ERCP: Endoscopic retrograde cholangiopancreatography; AKI: Acute kidney injury.